Good Psychotherapy Is Good Preparation and Integration 

Why preparation, integration, and psychotherapy matter in psychedelic-assisted psychotherapy.

This article reflects the clinical observations and opinions of Larry Shapiro, PhD. It is intended for educational purposes and to encourage discussion about the evolving practice of psychotherapy assisted by psychedelics.

Psychotherapy Assisted by Psychedelics

I always tell my patients that my goal for therapy is for them to stop coming. The timeline is different for everyone. Some people feel better quickly. Others need more time, support, accountability, or repetition of new behaviors and attitudes to get there.

One thing I have consistently observed, however, is that the velocity of change in psychotherapy can increase significantly with the introduction of psychedelics.

That may involve microdosing. It may involve larger experiences involving ketamine, psilocybin, ibogaine, or 5-MeO-DMT. With time and experience, I have become increasingly uncomfortable with the language used around psychedelic-assisted psychotherapy. I prefer to think of my work as psychotherapy assisted by psychedelics rather than psychedelic-assisted psychotherapy.

Turning Insight into Lasting Change 

That distinction matters clinically.

The critical question is not whether psychedelics work, but how to turn a psychedelic experience, macro or micro, into lasting change.

Psychedelics appear capable of temporarily opening critical periods for learning new information. In the case of macrodoses, each medicine has its own critical period that seems to be tied to the length of the psychedelic experience and the receptor sites activated in the brain. During those periods, people may become more emotionally open, less defensive, and more capable of seeing themselves, others, and their lives from a different perspective. But those opportunities do not organize themselves and, in many cases, have a time limit [1].

Psychotherapy needs to take advantage of them in a way that integrates those experiences for longer-term growth and symptom relief.

Without psychotherapy, some people may leave with insight but little lasting change. Most people come to therapy with some understanding and insight into their problem. The insight does not, on its own, lead to progress. They may understand themselves differently yet still struggle with relationships, work stress, avoidance, self-destructive behaviors, or the same patterns that brought them to treatment in the first place.

Whether someone is pursuing ketamine-assisted psychotherapy, psilocybin-assisted psychotherapy, or another psychedelic treatment, the challenge is often the same: how do you turn a meaningful experience into meaningful change?

Therapy Is Preparation

I’m a psychologist, so my bias is upfront. I treat people with persistent, treatment-resistant clinical problems. Before someone pursues a larger psychedelic experience, I want to understand how they think, how they respond to stress, how they manage relationships, how they cope when life becomes difficult, and how much responsibility they are willing to take for change. We explore family history, trauma, values, health, spirituality, behavioral patterns, and the environment they will eventually return to after the experience.

This is not simply screening—It is therapy.

Preparation is more than a checklist or an informed consent process. Good psychedelic preparation involves far more than reviewing risks, discussing expectations, and signing paperwork. It is active psychological work that begins way before the medicine is introduced. Ideally, by the time someone enters a psychedelic experience, they already have:

• A greater ability to tolerate difficult emotions
• More realistic expectations
• Greater psychological flexibility
• A stronger capacity to sit with uncertainty
• A clearer understanding of the patterns that keep them stuck
• Clearer intentions
• Evidence that they have already begun making changes in their daily lives

In my experience, sometimes reducing immediate distress before a psychedelic experience actually improves the quality of the experience itself. Desperation can narrow perception. Stability often allows for more curiosity, reflection, and emotional processing.

Therapy is Integration

“The psychedelic experience itself may last several hours. The afterglow may last days or weeks. The process of integration can take months or years.”

— Larry Shapiro, PhD

After the experience, the work continues.

I’ve been asked, “What is psychedelic integration?” I’ve also been told “I don’t get it,” meaning the concept of integration continues to feel foreign.

Integration is not simply talking about what someone saw, felt, or realized during a journey. Integration is the process of translating emotionally, intellectually, physically, or spiritually significant experiences into actual behavioral changes in daily life.

In my experience, integration is intimately related to preparation, and is where insight becomes behavior and where behavior reinforces lasting change.

In practical terms, integration is the process by which people learn to apply what they have experienced to relationships, work, health, parenting, and everyday life.

That may involve:

• Changing relationship patterns
• Improving communication
• Setting healthier boundaries
• Reducing avoidance behaviors
• Returning to work differently
• Becoming more emotionally available
• Developing healthier routines
• Tolerating uncertainty without immediately escaping it

This is where psychotherapy matters most.

What people often struggle with is doing something different when they are stressed, overwhelmed, frightened, angry, disappointed, or stuck in familiar situations.

The psychedelic experience itself may last several hours. The afterglow may last days or weeks. The process of integration can take months or years.

Current Psychedelic Therapy Models May Be Too Limited

A concern I have clinically is that many current psychedelic treatment models appear heavily influenced by research protocols rather than long-term psychotherapeutic thinking.

There are practical reasons for this.

Research studies require standardized structures. Retreats and emerging legal treatment programs need scalable models. Companies seeking FDA approval need to demonstrate that a medication is safe and effective. As a result, much of the attention naturally shifts toward the medicine rather than the psychotherapy surrounding it.

I understand that the field has to start somewhere.

Current regulations in states such as Colorado and Oregon appropriately focus on physical and psychological safety. Safety matters enormously. Colorado currently requires one preparation session and the offer of one integration session (Colorado Natural Medicine Health Act). Oregon requires one preparation session and no integration session (Oregon Health Authority). As a starting point, these standards are reasonable. But clinically, these minimum requirements are best viewed as safety standards rather than comprehensive psychotherapy. Safety alone is not the same thing as knowing a patient. Relatedly, when considering a psychedelic retreat, two or three group preparation and two to four group integration sessions cannot promote the depth of understanding and trust that a therapeutic relationship can have.

Knowing someone well enough to understand their coping style, trauma history, relationships, personality structure, environment, strengths, vulnerabilities, and capacity for change often takes considerably more time.

When Insight Isn’t Enough 

In my own practice, roughly a third of patients seeking psychotherapy assisted by psychedelics come to me after experiences at retreats or legal psychedelic treatment settings.

The questions I hear are usually practical:

• Why do I still feel stuck after a powerful psychedelic experience?
• I had a breakthrough during ketamine therapy. Why didn’t anything change afterward?
• How do I integrate a psychedelic experience into everyday life?
• Why did my anxiety come back after ketamine treatment?
• I felt emotionally opened up and then didn’t know what to do with it.
• How do I make the changes I saw during my journey actually last?

Occasionally, the question is even simpler:

“Nothing happened. Now what?”

I cannot say with certainty that more preparation or more integration would improve every outcome. Clinically, however, I suspect many patients would benefit from a more substantial therapeutic relationship before and after the psychedelic experience itself.

The Future of Clinical Psychedelic-Assisted Psychotherapy 

There are understandable financial, regulatory, and cultural incentives to focus heavily on the medicines. Medications are easier to standardize, market, scale, and study than psychotherapy.

But if the field becomes overly medicine-centered, I believe we risk minimizing the thing that often determines whether change becomes durable: the therapy part of psychedelic-assisted psychotherapy.

Psychedelics may increase emotional openness, cognitive flexibility, and capacity for learning. But if that period is not actively used to help someone think differently, relate differently, and behave differently, the opportunity may pass without substantial long-term change.

Good psychotherapy helps people translate insight into changes that are actually observable in daily life. It helps people improve relationships, handle stress more effectively, increase accountability, build healthier habits, make different choices, and sustain change over time. Psychedelics can be powerful catalysts for learning and change. But catalysts are not treatments by themselves.

In my experience, psychedelics have more impact if they are woven into therapy, as part of a continuum of therapy, not a midpoint bookended by a finite, predetermined number of meetings. The quality of preparation and integration often determines whether a psychedelic experience becomes an interesting memory or a catalyst for lasting change.

Good psychotherapy is good preparation. Good psychotherapy is good integration.

References

1. Nardou, R., Sawyer, E., Song, Y. L., Wilkinson, M., Padovan-Hernandez, Y., De Deus, J.L., Wright, N., Lama, C., Faltin, S., Goff, L. A., Stein-O’Brien, G. L., & Dölen, G (2023). Psychedelics Reopen the Social Reward Learning Critical Period. Nature, 618(7966), 790-798. https://doi.org/10.1038/s41586-023-06204-3